Kenneth L. Pitter

6.6k total citations · 3 hit papers
48 papers, 4.2k citations indexed

About

Kenneth L. Pitter is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Kenneth L. Pitter has authored 48 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 15 papers in Pulmonary and Respiratory Medicine and 13 papers in Oncology. Recurrent topics in Kenneth L. Pitter's work include Glioma Diagnosis and Treatment (10 papers), RNA Interference and Gene Delivery (7 papers) and Cell death mechanisms and regulation (6 papers). Kenneth L. Pitter is often cited by papers focused on Glioma Diagnosis and Treatment (10 papers), RNA Interference and Gene Delivery (7 papers) and Cell death mechanisms and regulation (6 papers). Kenneth L. Pitter collaborates with scholars based in United States, Canada and China. Kenneth L. Pitter's co-authors include Eric C. Holland, Loren D. Walensky, Moritz F. Kircher, Ruimin Huang, Gregory H. Bird, Cameron Brennan, Eric C. Holland, Ingo K. Mellinghoff, Carl Campos and John J. Halliday and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Kenneth L. Pitter

46 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A brain tumor molecular imaging strategy using a new triple-modality MRI-photoacoustic-Raman nanoparticle

2012 843 citations Moritz F. Kircher, Kenneth L. Pitter et al. profile →
BAX activation is initiated at a novel interaction site

2008 542 citations Evripidis Gavathiotis, Kenneth L. Pitter et al. profile →
Osteopontin-CD44 Signaling in the Glioma Perivascular Niche Enhances Cancer Stem Cell Phenotypes and Promotes Aggressive Tumor Growth

2014 403 citations Alexander Pietras, Amanda Katz et al. Cell stem cell profile →

Peers

Countries citing papers authored by Kenneth L. Pitter

Since Specialization

Citations

This map shows the geographic impact of Kenneth L. Pitter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth L. Pitter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth L. Pitter more than expected).

Fields of papers citing papers by Kenneth L. Pitter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth L. Pitter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth L. Pitter. The network helps show where Kenneth L. Pitter may publish in the future.

Co-authorship network of co-authors of Kenneth L. Pitter

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth L. Pitter. A scholar is included among the top collaborators of Kenneth L. Pitter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth L. Pitter. Kenneth L. Pitter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pan-Cancer Analysis Identifies a Ras-Related GTPase as a Potential Modulator of Cancer 2025 ·International Journal of Molecular Sciences ·(unknown), Kristyn Gumpper, Jelmer W. Poelstra, Kenneth L. Pitter, Zobeida Cruz‐Monserrate	1
2	Treatment Patterns and Outcomes for Patients with Ampullary Carcinoma Who Do Not Undergo Surgery 2023 ·Cancers ·(unknown), Jordan M. Cloyd, Ashish Manne, Kenneth L. Pitter, Dayssy A. Diaz, Jose G. Bazan, Eric D. Miller	2
3	Disparities in outcomes and access to therapy options in hepatocellular carcinoma 2023 ·JNCI Journal of the National Cancer Institute ·(unknown), Yevgeniya Gokun, (unknown), Laura A. Dawson, Eric D. Miller, Charles R. Thomas, Kenneth L. Pitter, Lanla Conteh, Dayssy A. Diaz	5
4	Multidisciplinary management in the treatment of intrahepatic cholangiocarcinoma 2023 ·CA A Cancer Journal for Clinicians ·Samantha M. Ruff, Dayssy A. Diaz, Kenneth L. Pitter, (unknown), Timothy M. Pawlik	5
5	Systematic Comparison of Pancreatic Ductal Adenocarcinoma Models Identifies a Conserved Highly Plastic Basal Cell State 2022 ·Cancer Research ·Kenneth L. Pitter, Olivera Grbovic-Huezo, Simon Joost, Anupriya Singhal, (unknown), Katherine Wu, Matilda Holm, (unknown), Arjun Bhutkar, Anna Hudson, Nicolas Lecomte, Elisa de Stanchina, Ronan Chaligné, Christine A. Iacobuzio–Donahue, Dana Pe’er, Tuomas Tammela	11
6	TP53 mutations increase radioresistance in rhabdomyosarcoma and Ewing sarcoma 2021 ·British Journal of Cancer ·Dana L. Casey, Kenneth L. Pitter, Leonard H. Wexler, Emily K. Slotkin, Gaorav P. Gupta, Suzanne L. Wolden	29
7	Genomic Determinants of Clinical Outcomes in Rhabdomyosarcoma 2019 ·Clinical Cancer Research ·Dana L. Casey, Leonard H. Wexler, Kenneth L. Pitter, Robert Samstein, Emily K. Slotkin, Suzanne L. Wolden	31
8	High-dose radiation therapy is needed for intracranial control and long-term survival in patients with non-seminomatous germ cell tumor brain metastases 2019 ·Journal of Neuro-Oncology ·Dana L. Casey, Kenneth L. Pitter, Brandon S. Imber, Andrew Lin, Timothy A. Chan, Kathryn Beal, Yoshiya Yamada, Darren R. Feldman, Jonathan T. Yang	5
9	Endoluminal high-dose-rate brachytherapy for locally recurrent or persistent esophageal cancer 2018 ·Brachytherapy ·Amandeep Taggar, Kenneth L. Pitter, Gil’ad N. Cohen, Mark Schattner, Hans Gerdes, Arnold J. Markowitz, David H. Ilson, (unknown), John Cuaron, Karyn A. Goodman, Abraham J. Wu	8
10	Increased HOXA5 expression provides a selective advantage for gain of whole chromosome 7 in IDH wild-type glioblastoma 2018 ·Genes & Development ·Patrick J. Cimino, Youngmi Kim, Hua‐Jun Wu, Jes Alexander, Hans‐Georg Wirsching, Frank Szulzewsky, Kenneth L. Pitter, Tatsuya Ozawa, Jiguang Wang, Julio Vazquez, Sonali Arora, Raúl Rabadán, Ross L. Levine, Franziska Michor, Eric C. Holland	38
11	Treatment of Vulvar Mycosis Fungoides Tumors With Localized Radiotherapy 2018 ·Clinical Lymphoma Myeloma & Leukemia ·Shamir Geller, Kenneth L. Pitter, Alison J. Moskowitz, Sarah McCue Horwitz, Joachim Yahalom, Patricia L. Myskowski	5
12	High Precision Imaging of Microscopic Spread of Glioblastoma with a Targeted Ultrasensitive SERRS Molecular Imaging Probe 2016 ·Theranostics ·Ruimin Huang, Stefan Harmsen, (unknown), Hazem Karabeber, Kenneth L. Pitter, Eric C. Holland, Moritz F. Kircher	91
13	Optimization of radiation dosing schedules for proneural glioblastoma 2015 ·Journal of Mathematical Biology ·(unknown), Kenneth L. Pitter, Eric C. Holland, Franziska Michor, Kevin Leder	26
14	Radiographic Features, Patterns of Treatment Failure, and Clinical Outcomes in 56 Cases of Molecularly Subtyped Glioblastoma Multiforme Patients 2014 ·International Journal of Radiation OncologyBiologyPhysics ·Quincey LaPlant, Kenneth L. Pitter, Robert J. Young, Yoshiya Yamada, Timothy A. Chan, Jason T. Huse, Cameron Brennan, Kathryn Beal	1
15	Osteopontin-CD44 Signaling in the Glioma Perivascular Niche Enhances Cancer Stem Cell Phenotypes and Promotes Aggressive Tumor Growth breakdown → 2014 ·Cell stem cell ·Alexander Pietras, Amanda Katz, Elin Ekström, (unknown), John J. Halliday, Kenneth L. Pitter, Jillian L. Werbeck, Nduka Amankulor, Jason T. Huse, Eric C. Holland	403
16	Mathematical Modeling of PDGF-Driven Glioblastoma Reveals Optimized Radiation Dosing Schedules 2014 ·Cell ·Kevin Leder, Kenneth L. Pitter, Quincey LaPlant, Dolores Hambardzumyan, Brian D. Ross, Timothy A. Chan, Eric C. Holland, Franziska Michor	193
17	Astrocyte-Specific Expression Patterns Associated with the PDGF-Induced Glioma Microenvironment 2012 ·PLoS ONE ·Amanda Katz, Nduka Amankulor, Kenneth L. Pitter, Karim Y. Helmy, Massimo Squatrito, Eric C. Holland	68
18	A stapled BIM peptide overcomes apoptotic resistance in hematologic cancers 2012 ·Journal of Clinical Investigation ·James L. LaBelle, Samuel G. Katz, Gregory H. Bird, Evripidis Gavathiotis, Michelle L. Stewart, (unknown), Jill K. Fisher, Marina Godes, Kenneth L. Pitter, Andrew L. Kung, Loren D. Walensky	144
19	The EphA2 Receptor Drives Self-Renewal and Tumorigenicity in Stem-like Tumor-Propagating Cells from Human Glioblastomas 2012 ·Cancer Cell ·Elena Binda, Alberto Visioli, Fabrizio Giani, Giuseppe Lamorte, Massimiliano Copetti, Kenneth L. Pitter, Jason T. Huse, Laura Cajola, Nadia Zanetti, Francesco DiMeco, Lidia De Filippis, Annunziato Mangiola, Giulio Maira, Carmelo Anile, Pasquale De Bonis, Brent A. Reynolds, Elena B. Pasquale, Angelo L. Vescovi	169
20	Correction: Perifosine and CCI 779 Co-Operate to Induce Cell Death and Decrease Proliferation in PTEN-Intact and PTEN-Deficient PDGF-Driven Murine Glioblastoma 2011 ·PLoS ONE ·Kenneth L. Pitter, (unknown), (unknown), (unknown), Fei Li, Nikki Charles, Michelle S. Bradbury, Oren J. Becher, Thomas L. Chenevert, Alnawaz Rehemtulla, Brian D. Ross, Eric C. Holland, (unknown)	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact